Literature DB >> 17475921

Toll-like receptor 4 suppression leads to islet allograft survival.

Alyssa Goldberg1, Margherita Parolini, Beek Y Chin, Eva Czismadia, Leo E Otterbein, Fritz H Bach, Hongjun Wang.   

Abstract

Carbon monoxide (CO) exposure of an islet donor frequently leads to islet allograft long-term survival and tolerance in recipients. We show here that CO confers its protective effects at least in part by suppressing Toll-like receptor 4 (TLR4) up-regulation in pancreatic beta cells. TLR4 is normally up-regulated in islets during the isolation procedure; donor treatment with CO suppresses TLR4 expression in isolated islets as well as in transplanted grafts. TLR4 up-regulation allows initiation of inflammation, which leads to islet allograft rejection; islet grafts from TLR4-deficient mice survive indefinitely in BALB/c recipients and show significantly less inflammation at various days after transplantation compared with grafts from a control donor. Isolated islets preinfected with a TLR4 dominant negative virus before transplantation demonstrated prolonged survival in recipients. Despite the salutary effects of TLR4 suppression, HO-1 expression is still needed in the recipient for islet survival: TLR4-deficient islets were rejected promptly after being transplanted into recipients in which HO-1 activity was blocked. In addition, incubation of an insulinoma cell line, betaTC3, with an anti-TLR4 antibody protects those cells from cytokine-induced apoptosis. Our data suggest that TLR4 induction in beta cells is involved in beta cell death and graft rejection after transplantation. CO exposure protects islets from rejection by blocking TLR4 up-regulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17475921     DOI: 10.1096/fj.06-7910com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  28 in total

1.  The synthetic liver X receptor agonist GW3965 reduces tissue factor production and inflammatory responses in human islets in vitro.

Authors:  H Scholz; T Lund; M K Dahle; J L Collins; O Korsgren; J E Wang; A Foss
Journal:  Diabetologia       Date:  2009-05-05       Impact factor: 10.122

Review 2.  Inflammation and transplantation tolerance.

Authors:  Daniel R Goldstein
Journal:  Semin Immunopathol       Date:  2011-02-18       Impact factor: 9.623

3.  Carbon Monoxide Inhibits Islet Apoptosis via Induction of Autophagy.

Authors:  Do-Sung Kim; Lili Song; Jingjing Wang; Hongju Wu; Wenyu Gou; Wanxing Cui; Jae-Sung Kim; Hongjun Wang
Journal:  Antioxid Redox Signal       Date:  2017-11-27       Impact factor: 8.401

4.  Toll-like receptor 4 contributes to small intestine allograft rejection.

Authors:  Sheri M Krams; Mouer Wang; Ricardo O Castillo; Takashi Ito; Lori Phillips; John Higgins; Neeraja Kambham; Carlos O Esquivel; Olivia M Martinez
Journal:  Transplantation       Date:  2010-12-27       Impact factor: 4.939

5.  Early Subretinal Allograft Rejection Is Characterized by Innate Immune Activity.

Authors:  Kevin P Kennelly; Toby M Holmes; Deborah M Wallace; Cliona O'Farrelly; David J Keegan
Journal:  Cell Transplant       Date:  2017-01-20       Impact factor: 4.064

Review 6.  Innate immunity and organ transplantation: focus on lung transplantation.

Authors:  Daniel Kreisel; Daniel R Goldstein
Journal:  Transpl Int       Date:  2012-08-21       Impact factor: 3.782

7.  TLR4 and Insulin Resistance.

Authors:  Jane J Kim; Dorothy D Sears
Journal:  Gastroenterol Res Pract       Date:  2010-08-10       Impact factor: 2.260

Review 8.  The role of inflammation in insulitis and beta-cell loss in type 1 diabetes.

Authors:  Décio L Eizirik; Maikel L Colli; Fernanda Ortis
Journal:  Nat Rev Endocrinol       Date:  2009-04       Impact factor: 43.330

9.  Inhibition of TLR4 signaling prolongs Treg-dependent murine islet allograft survival.

Authors:  N Zhang; B Krüger; G Lal; Y Luan; A Yadav; W Zang; M Grimm; A M Waaga-Gasser; B Murphy; J S Bromberg; B Schröppel
Journal:  Immunol Lett       Date:  2009-10-29       Impact factor: 3.685

10.  PTPN2, a candidate gene for type 1 diabetes, modulates interferon-gamma-induced pancreatic beta-cell apoptosis.

Authors:  Fabrice Moore; Maikel L Colli; Miriam Cnop; Mariana Igoillo Esteve; Alessandra K Cardozo; Daniel A Cunha; Marco Bugliani; Piero Marchetti; Décio L Eizirik
Journal:  Diabetes       Date:  2009-03-31       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.